Opinion

Video

Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates

The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.

Related Videos
A panel of 5 experts on RSV
A panel of 5 experts on RSV
A panel of 4 experts on CLL
A panel of 4 experts on CLL
CH LogoCenter for Biosimilars Logo